{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T18:40:03Z","timestamp":1730659203816,"version":"3.28.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,3]]},"DOI":"10.7759\/cureus.72931","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T18:14:26Z","timestamp":1730657666000},"source":"Crossref","is-referenced-by-count":0,"title":["Mitral Valve Prolapse in a Patient With Polycystic Kidney Disease"],"prefix":"10.7759","author":[{"given":"Leticia","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipa","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula S","family":"Fazendas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helder H","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann C","year":"2018","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJ, Torres VE. Polycystic kidney disease. Nat Rev Dis Primers. 2018, 4:50. 10.1038\/s41572-018-0047-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw240","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey CJ","year":"2017","unstructured":"Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ, Czerwiec FS. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transplant. 2017, 32:1356-63. 10.1093\/ndt\/gfw240","journal-title":"Nephrol Dial Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2019.100887","article-title":"Update and review of adult polycystic kidney disease","volume":"66","author":"Colbert GB","year":"2020","unstructured":"Colbert GB, Elrggal ME, Gaur L, Lerma EV. Update and review of adult polycystic kidney disease. Dis Mon. 2020, 66:100887. 10.1016\/j.disamonth.2019.100887","journal-title":"Dis Mon"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000028643.17901.42","article-title":"Genetics and pathogenesis of polycystic kidney disease","volume":"13","author":"Igarashi P","year":"2002","unstructured":"Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol. 2002, 13:2384-98. 10.1097\/01.asn.0000028643.17901.42","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres V","year":"2007","unstructured":"Torres V, Harris P, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007, 369:1287-301. 10.1016\/S0140-6736(07)60601-1","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.07.037","article-title":"Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016","volume":"67","author":"Chebib FT","year":"2016","unstructured":"Chebib FT, Torres VE. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016. Am J Kidney Dis. 2016, 67:792-810. 10.1053\/j.ajkd.2015.07.037","journal-title":"Am J Kidney Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199010183231601","article-title":"The diagnosis and prognosis of autosomal dominant polycystic kidney disease","volume":"323","author":"Parfrey PS","year":"1990","unstructured":"Parfrey PS, Bear JC, Morgan J, et al.. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med. 1990, 323:1085-90. 10.1056\/NEJM199010183231601","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1590\/s0100-879x2006000400014","article-title":"Renal and extrarenal manifestations of autosomal dominant polycystic kidney disease","volume":"39","author":"Rom\u00e3o EA","year":"2006","unstructured":"Rom\u00e3o EA, Moys\u00e9s Neto M, Teixeira SR, Muglia VF, Vieira-Neto OM, Dantas M. Renal and extrarenal manifestations of autosomal dominant polycystic kidney disease. Braz J Med Biol Res. 2006, 39:533-8. 10.1590\/s0100-879x2006000400014","journal-title":"Braz J Med Biol Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70001-6","article-title":"Extrarenal manifestations of autosomal dominant polycystic kidney disease","volume":"1016","author":"Torres V","year":"1999","unstructured":"Torres V. Extrarenal manifestations of autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1999, 1016:14-6. 10.1016\/S0272-6386(99)70001-6","journal-title":"Am J Kidney Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/1573402111309010007","article-title":"The genetics of vascular complications in autosomal dominant polycystic kidney disease (ADPKD)","volume":"9","author":"Rossetti S","year":"2013","unstructured":"Rossetti S, Harris PC. The genetics of vascular complications in autosomal dominant polycystic kidney disease (ADPKD). Curr Hypertens Rev. 2013, 9:37-43. 10.2174\/1573402111309010007","journal-title":"Curr Hypertens Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.84a.16107","article-title":"Autosomal dominant polycystic kidney disease and the heart and brain","volume":"84","author":"Krishnappa V","year":"2017","unstructured":"Krishnappa V, Vinod P, Deverakonda D, Raina R. Autosomal dominant polycystic kidney disease and the heart and brain. Cleve Clin J Med. 2017, 84:471-81. 10.3949\/ccjm.84a.16107","journal-title":"Cleve Clin J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000343281","article-title":"Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease","volume":"36","author":"Helal I","year":"2012","unstructured":"Helal I, Reed B, Mettler P, Mc Fann K, Tkachenko O, Yan XD, Schrier RW. Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol. 2012, 36:362-70. 10.1159\/000343281","journal-title":"Am J Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V5122048","article-title":"Causes of death in autosomal dominant polycystic kidney disease","volume":"5","author":"Fick GM","year":"1995","unstructured":"Fick GM, Johnson AM, Hammond WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995, 5:2048-56. 10.1681\/ASN.V5122048","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.29216","article-title":"Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1","volume":"38","author":"Lumiaho A","year":"2001","unstructured":"Lumiaho A, Ik\u00e4heimo R, Miettinen R, et al.. Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am J Kidney Dis. 2001, 38:1208-16. 10.1053\/ajkd.2001.29216","journal-title":"Am J Kidney Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab312","article-title":"An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International","volume":"37","author":"M\u00fcller RU","year":"2022","unstructured":"M\u00fcller RU, Messchendorp AL, Birn H, et al.. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrol Dial Transplant. 2022, 37:825-39. 10.1093\/ndt\/gfab312","journal-title":"Nephrol Dial Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/312593-mitral-valve-prolapse-in-a-patient-with-polycystic-kidney-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T18:14:27Z","timestamp":1730657667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/312593-mitral-valve-prolapse-in-a-patient-with-polycystic-kidney-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,3]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.72931","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,3]]}}}